Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.47 USD | -1.40% | -6.92% | +162.23% |
Apr. 10 | Arcutis Biotherapeutics, Inc. Announces Chief Financial Officer Changes | CI |
Mar. 18 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index | CI |
Evolution of the average Target Price on Arcutis Biotherapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Arcutis Biotherapeutics, Inc.
Mizuho Securities | |
Needham & Co. | |
Morgan Stanley | |
JonesTrading Institutional Services | |
Goldman Sachs | |
Truist Securities | |
Guggenheim |
EPS Revisions
- Stock Market
- Equities
- ARQT Stock
- Consensus Arcutis Biotherapeutics, Inc.